As of Sep 18
| -0.25 / -4.21%|
The 3 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +216.34% increase from the last price of 5.69.
The current consensus among 3 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.